These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6920506)

  • 1. [General indications for and risks of immunoglobulin treatment].
    Morell A
    Krankenpfl J; 1982 Jun; 20(6):8-11. PubMed ID: 6920506
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and therapy with immunoglobulin SRK].
    Schnoz M; Ryser DH; Barandun S; Eckmann L
    Helv Chir Acta; 1979 May; 46(1-2):111-3. PubMed ID: 38227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoglobulins].
    Visco G
    Policlinico Prat; 1971 Mar; 78(6):245-50. PubMed ID: 4103723
    [No Abstract]   [Full Text] [Related]  

  • 4. The Nuts and Bolts of Immunoglobulin Treatment for Antibody Deficiency.
    Wasserman RL
    J Allergy Clin Immunol Pract; 2016; 4(6):1076-1081.e3. PubMed ID: 27836057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic use of immunoglobulins.
    Stiehm ER; Orange JS; Ballow M; Lehman H
    Adv Pediatr; 2010; 57(1):185-218. PubMed ID: 21056739
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoglobulin replacement therapy for primary immunodeficiencies.
    Peter JG; Chapel H
    Immunotherapy; 2014; 6(7):853-69. PubMed ID: 25290417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic use of immunoglobulins in children (author's transl)].
    Hitzig WH
    Blut; 1980 Mar; 40(3):215-24. PubMed ID: 6988023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of opsonification in antimicrobial defense and its therapeutic consequences].
    Mondorf AW; Schaffstein A; Fischer M
    Klin Anasthesiol Intensivther; 1976; (12):49-67. PubMed ID: 1029768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoglobulins: multiple potential therapeutic proteins for use in immune deficits].
    Adoue D; Grivel T
    Rev Med Interne; 2010 Dec; 31(9 Suppl):H9-11. PubMed ID: 20965374
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacoeconomics of immunoglobulins in primary immunodeficiency.
    Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):375-86. PubMed ID: 19670998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of immunoglobulins in practice].
    Weber-Oldecop H
    ZFA (Stuttgart); 1981 Jan; 57(3):169-76. PubMed ID: 7210836
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoglobulin therapy: methods of delivery.
    Ballow M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of intravenous immunoglobulin G (IVIG).
    Looney RJ; Huggins J
    Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin deficiency syndrome.
    Arcadi JA
    Br Med J; 1973 Mar; 1(5855):743. PubMed ID: 4694705
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous immunoglobulins in dermatology].
    Nydegger U; Hunziker T
    Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118
    [No Abstract]   [Full Text] [Related]  

  • 16. Injectable immunoglobulins, immunodeficiency and off-label clinical trials, source plasma and ethical concerns and debates.
    Garraud O
    Transfus Apher Sci; 2019 Aug; 58(4):529-530. PubMed ID: 31256945
    [No Abstract]   [Full Text] [Related]  

  • 17. The patient: Emerging clinical applications of intravenous immunoglobulin.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching immunoglobulin products, what are the implications? Result of 2018 census of immunology centres.
    Bethune C; Herriot R
    Clin Med (Lond); 2019 May; 19(3):201-204. PubMed ID: 31092511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New possibilities for immunoglobulin substitution in antibody deficiency syndrome].
    Joller PW; Barandun S; Hitzig WH
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1451-3. PubMed ID: 7280594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.